421 related articles for article (PubMed ID: 25168947)
21. Prothrombin complex concentrate (Beriplex P/N)-related renal and cerebral infarctions in a patient with warfarin-associated intracerebral hemorrhage.
Lin SY; Tang SC; Shen LJ; Jeng JS
J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):e15-6. PubMed ID: 25282184
[TBL] [Abstract][Full Text] [Related]
22. Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model.
Pragst I; Zeitler SH; Doerr B; Kaspereit FJ; Herzog E; Dickneite G; van Ryn J
J Thromb Haemost; 2012 Sep; 10(9):1841-8. PubMed ID: 22812619
[TBL] [Abstract][Full Text] [Related]
23. New oral anticoagulant-induced bleeding: clinical presentation and management.
Levy JH; Levi M
Clin Lab Med; 2014 Sep; 34(3):575-86. PubMed ID: 25168943
[TBL] [Abstract][Full Text] [Related]
24. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF
Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997
[TBL] [Abstract][Full Text] [Related]
25. Four-factor prothrombin complex concentrate versus plasma for urgent vitamin K antagonist reversal: new evidence.
Sarode R
Clin Lab Med; 2014 Sep; 34(3):613-21. PubMed ID: 25168946
[TBL] [Abstract][Full Text] [Related]
26. Prothrombin complex concentrate for non-vitamin K oral anticoagulant reversal: good enough for now?
Makris M
J Thromb Haemost; 2014 Sep; 12(9):1425-7. PubMed ID: 25039898
[No Abstract] [Full Text] [Related]
27. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose.
Holland L; Warkentin TE; Refaai M; Crowther MA; Johnston MA; Sarode R
Transfusion; 2009 Jun; 49(6):1171-7. PubMed ID: 19210325
[TBL] [Abstract][Full Text] [Related]
28. An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal.
Altorjay Á; Szabó É; Boda Z; Kramer L; Ngo LY; Engl W; Firth CL; Ahlstrom ER; Gelmont DM; Pabinger I
Thromb Res; 2015 Mar; 135(3):485-91. PubMed ID: 25613927
[TBL] [Abstract][Full Text] [Related]
29. Perioperative use of prothrombin complex concentrates.
Colomina MJ; Díez Lobo A; Garutti I; Gómez-Luque A; Llau JV; Pita E
Minerva Anestesiol; 2012 Mar; 78(3):358-68. PubMed ID: 22357373
[TBL] [Abstract][Full Text] [Related]
30. Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal.
Pabinger I; Tiede A; Kalina U; Knaub S; Germann R; Ostermann H;
Ann Hematol; 2010 Mar; 89(3):309-16. PubMed ID: 19787352
[TBL] [Abstract][Full Text] [Related]
31. Newer oral anticoagulants: a review of laboratory monitoring options and reversal agents in the hemorrhagic patient.
Miyares MA; Davis K
Am J Health Syst Pharm; 2012 Sep; 69(17):1473-84. PubMed ID: 22899742
[TBL] [Abstract][Full Text] [Related]
32. [CORRECTION OF HEMOSTASIS WITH BLOOD PRODUCTS IN THE SURGICAL TREATMENT OF CONGENITAL HEART DISEASE IN INFANTS AND YOUNG CHILDREN].
Rybka MM; Samsonova NN; Klimovich LG; Rogalskaya EA; Khichagov DY; Tataryan FE
Anesteziol Reanimatol; 2015; 60(5):42-6. PubMed ID: 26852579
[TBL] [Abstract][Full Text] [Related]
33. [Substitution therapy with prothrombin complex concentrates in acquired coagulation disorders].
Fischer M
Wien Klin Wochenschr; 1983 Feb; 95(3):82-5. PubMed ID: 6858171
[TBL] [Abstract][Full Text] [Related]
34. Current state of knowledge on oral anticoagulant reversal using procoagulant factors.
Nitzki-George D; Wozniak I; Caprini JA
Ann Pharmacother; 2013 Jun; 47(6):841-55. PubMed ID: 23695644
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteers.
Ostermann H; Haertel S; Knaub S; Kalina U; Jung K; Pabinger I
Thromb Haemost; 2007 Oct; 98(4):790-7. PubMed ID: 17938803
[TBL] [Abstract][Full Text] [Related]
36. [Use and abuse of prothrombin-complex concentrates].
Veltkamp JJ; Siewertz van Reesema DR; Boekhout-Mussert MJ
Ned Tijdschr Geneeskd; 1978 May; 122(21):766-7. PubMed ID: 652091
[No Abstract] [Full Text] [Related]
37. Hemostatic agents for bleeding: recombinant-activated factor VII and beyond.
Franchini M; Crestani S; Frattini F; Sissa C; Bonfanti C
Semin Thromb Hemost; 2015 Apr; 41(3):342-7. PubMed ID: 24937097
[TBL] [Abstract][Full Text] [Related]
38. Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding.
Evans G; Luddington R; Baglin T
Br J Haematol; 2001 Dec; 115(4):998-1001. PubMed ID: 11843839
[TBL] [Abstract][Full Text] [Related]
39. Prothrombal: a new concentrate of human prothrombin complex for clinical use.
Bruning PF; Loeliger EA
Br J Haematol; 1971 Oct; 21(4):377-98. PubMed ID: 5001176
[No Abstract] [Full Text] [Related]
40. Treatment of intracerebral hemorrhage associated with new oral anticoagulant use: the neurologist's view.
Veltkamp R; Horstmann S
Clin Lab Med; 2014 Sep; 34(3):587-94. PubMed ID: 25168944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
